We could demonstrate that rupatadine can effectively inhibit in vitro cell proliferation and migration of clear cell, serous, BRCA1 mutant, and endometrioid ovarian cancer cells. Here, BRCA1 is linked to ovarian endometrioid adenocarcinoma.